Brief: Iterum Therapeutics Provides Update From FDA Type A Meeting Regarding Oral Sulopenem

Iterum Therapeutics

28/09/2021 13:17

Sept 28 (Reuters) - Iterum Therapeutics PLC  ITRM.O :
    * ITERUM THERAPEUTICS PROVIDES UPDATE FROM FDA TYPE A
MEETING
REGARDING ORAL SULOPENEM
    * ITERUM THERAPEUTICS PROVIDES UPDATE FROM FDA TYPE A
MEETING
REGARDING ORAL SULOPENEM
    * ITERUM THERAPEUTICS PLC - NOTES THAT CASH, CASH
EQUIVALENTS AND
SHORT-TERM INVESTMENTS WERE $91.5 MILLION AT END OF Q2 OF 2021
    * ITERUM THERAPEUTICS PLC - BELIEVES THAT IT IS WELL
POSITIONED
FINANCIALLY TO FUND ITS OPERATIONS INTO SECOND HALF OF 2023
    * ITERUM THERAPEUTICS - CURRENTLY EVALUATING OPTIMAL DESIGN
FOR AN
ADDITIONAL PHASE 3 UUTI STUDY TO BE CONDUCTED PRIOR TO POTENTIAL
RESUBMISSION OF NDA

Source text for Eikon:  ID:nGNXbwvKjd 
Further company coverage:  ITRM.O 

 ((Reuters.Briefs@thomsonreuters.com;))